BaioSite-B (02315) RenMab technology platform re-authorised Japanese patent continuous deepening RenMice global patent layout of human antibodies/TCR platform

Wisdom Financial News APP News, BeiAo SaiTu-B (02315) announced that its independently developed key technology of the fully human antibody mouse RenMab platform has been granted an invention patent certificate by the Japan Patent Office (JPO). This is another key progress in the global intellectual property protection of the BeiAo SaiTu RenMice fully human antibody platform family, marking the steady progress and deepening of its systematic global patent layout strategy, fully demonstrating the innovation and international recognition of its core technology.